Related Experiment Video
Updated: Dec 2, 2025

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Published on: January 27, 2019
Updates on pediatric sepsis
Andrea T Cruz1, Roni D Lane2, Fran Balamuth3
1Sections of Emergency Medicine and Infectious Disease Department of Pediatrics Baylor College of Medicine Houston Texas USA.
Insights
Recognizing and treating pediatric sepsis in the emergency department (ED) is critical. Updated guidelines and quality improvement programs aid in timely interventions for better outcomes in children with sepsis.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Emergency medicine
Background:
- Pediatric sepsis presents diagnostic challenges in the ED due to non-specific symptoms and children's compensatory mechanisms.
- Timely recognition and treatment are crucial for improving sepsis outcomes in children, reducing morbidity and mortality.
Purpose of the Study:
- To review clinical, laboratory, and technical tools for recognizing, treating, and reassessing pediatric sepsis in the ED.
- To frame the 2020 updated pediatric sepsis guidelines within ED interventions.
Main Methods:
- Review of clinical, laboratory, and technical modalities for sepsis recognition and management.
- Analysis of the 2020 updated pediatric sepsis guidelines, focusing on ED interventions.
- Discussion of evidence gaps and the need for further research.
Main Results:
- Quality improvement programs have enhanced sepsis treatment reliability in US institutions.
- The 2020 guidelines provide updated recommendations for antibiotic administration, fluid resuscitation, and vasoactive agents in pediatric sepsis.
- Limited evidence base for treatment and management components necessitates further large-scale trials.
Conclusions:
- Despite substantial burden, progress in understanding and managing pediatric sepsis has led to revised guidelines.
- Local quality improvement programs are emphasized for optimizing sepsis management in children.
- Ongoing research is vital to strengthen the evidence base for pediatric sepsis treatment.
Abstract:
Sepsis, defined as an infection with dysregulated host response leading to life-threatening organ dysfunction, continues to carry a high potential for morbidity and mortality in children. The recognition of sepsis in children in the emergency department (ED) can be challenging, related to the high prevalence of common febrile infections, poor specificity of discriminating features, and the capacity of children to compensate until advanced stages of shock. Sepsis outcomes are strongly dependent on the timeliness of recognition and treatment, which has led to the successful implementation of quality improvement programs, increasing the reliability of sepsis treatment in many US institutions. We review clinical, laboratory, and technical modalities that can be incorporated into ED practice to facilitate the recognition, treatment, and reassessment of children with suspected sepsis. The 2020 updated pediatric sepsis guidelines are reviewed and framed in the context of ED interventions, including guidelines for antibiotic administration, fluid resuscitation, and the use of vasoactive agents. Despite a large body of literature on pediatric sepsis epidemiology in recent years, the evidence base for treatment and management components remains limited, implying an urgent need for large trials in this field. In conclusion, although the burden and impact of pediatric sepsis remains substantial, progress in our understanding of the disease and its management have led to revised guidelines and the available data emphasizes the importance of local quality improvement programs.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution

